MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ALT has $335,630K in assets. $51,643K in debts. $97,601K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2955.72%
Quick Ratio
2955.72%
Cash Ratio
861.97%
Debt to Asset Ratio
15.39%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts and other receivables
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accumulated other comprehensive ...
    • Others

Balance Sheets
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
97,601 61,236 183,105
Restricted cash
42 42 42
Total cash, cash equivalents and restricted cash
97,643 61,278 183,147
Short-term investments
233,939 149,540 -
Accounts and other receivables
1,665 845 321
Income tax and r&d incentive receivables
-547 557
Prepaid expenses and other current assets
1,429 4,405 4,397
Total current assets
334,676 216,615 188,422
Property and equipment, net
208 337 364
Other assets
746 1,495 1,564
Total assets
335,630 218,447 190,350
Accounts payable
1,530 4,804 851
Accrued expenses and other current liabilities
9,793 7,802 8,369
Total current liabilities
11,323 12,606 9,220
Term loan, noncurrent
34,505 14,445 14,332
Other noncurrent liabilities
5,815 5,795 5,431
Total liabilities
51,643 32,846 28,983
Common stock, 0.0001 par value 200,000,000 shares authorized 130,221,154 and 110,882,735 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
13 10 9
Additional paid-in capital
961,244 812,732 769,508
Accumulated deficit
-672,046 -622,125 -603,111
Accumulated other comprehensive loss, net
-5,224 -5,016 -5,039
Total stockholders' equity
283,987 185,601 161,367
Total liabilities and stockholders' equity
335,630 218,447 190,350
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$97,601K Restricted cash$42K Short-term investments$233,939K Total cash, cashequivalents and restricted...$97,643K Accounts and otherreceivables$1,665K Prepaid expenses andother current assets$1,429K Total current assets$334,676K Other assets$746K Property and equipment,net$208K Total assets$335,630K Total liabilities andstockholders' equity$335,630K Total stockholders'equity$283,987K Total liabilities$51,643K Accumulated deficit-$672,046K Accumulated othercomprehensive loss, net-$5,224K Additional paid-in capital$961,244K Term loan,noncurrent$34,505K Total currentliabilities$11,323K Other noncurrentliabilities$5,815K Common stock, 0.0001par value...$13K Accrued expenses andother current...$9,793K Accounts payable$1,530K

Altimmune, Inc. (ALT)

Altimmune, Inc. (ALT)